Login / Signup

New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.

Eric LiozonSimon ParreauStéphanie DumonteilGuillaume GondranHoly BezanaharyKim Heang LyAnne Laure Fauchais
Published in: Rheumatology international (2023)
Biopsy-proven GCA presenting with lower ESR and CRP is not an exceptional occurrence. It is clinically less typical but carries similar ischemic risk to other forms of the disease. Conversely, the late GCA prognosis of these patients is excellent.
Keyphrases